Sharp Increase in COVID-19 Deaths AFTER Vaccination
Jarle Aarstad
Jarle Aarstad’s Substack
Sharp Increase in COVID-19 Deaths Among Young People in Norway AFTER Vaccination
According to a recently published study by, 74 young people in Norway under the age of 30 developed myocarditis – inflammation of the heart muscle – as a direct consequence of COVID-19 vaccination.
Myocarditis is one of the deadliest conditions that can strike young people, but the grim statistics only become obvious after a few years.
In addition, the Norwegian Medicines Agency (Legemiddelverket – Directorate for Medical Products) has classified 1,453 of 16,085 reported adverse events following COVID-19 vaccination in young people under 30 as serious.
Was the COVID-19 vaccination of young people worth the price? | Based on these grim figures, it is legitimate to ask: was COVID-19 vaccination of young people worth the price? The answer is yes only if the benefits outweigh the significant drawbacks. That is, if the COVID-19 vaccine prevented many COVID-19 deaths in the young Norwegian population. But did it do so?
Obtaining exact annual figures for the number of people under 30 who died of COVID-19 in Norway is difficult, as the numbers are very small. I therefore asked Grok, whom I do not believe biases answers systematically in one direction or another, and below I present the low-to-high generated estimates.
COVID-19-associated deaths:
* 2020: 0–6 (no vaccine)
* 2021: 0–6 (vaccination began for most young people in the second half of the year)
* 2022: 5–10 (vaccination with at least one dose offered to most young people)
* 2023: 3–6
* 2024: 0–3
* 2025: 0–3
The numbers are consistently low, but we observe a strong relative increase in 2022, after most young people had been offered at least one vaccination dose. Some may claim that the deaths increased in 2022 due to the high spread of the Omicron variant, but if so, there is limited evidence of a vaccine effect against transmission or death, rather on the contrary.
COVID-19 deaths among young people are roughly similar to those of influenza | It is also worth keeping in mind that between 2015 and 2019, an average of 2 to 5 people in Norway under the age of 30 died of influenza each year. Once again, I believe Grok did not systematically bias these estimates in any particular direction.
In other words, influenza- and COVID-19-related deaths do not differ significantly from each other, with the exception of 2022, after COVID-19 vaccination, when relatively more young people died from the latter cause.
According to the Norwegian Institute of Public Health (FHI), the statistics on influenza and COVID-19 deaths among young people also align with those for the entire population as of December 2020 – before the vaccine rollout – except during severe influenza seasons, which have historically claimed more lives.
So what was the benefit of young people taking the COVID-19 vaccine? – None [at all.]
When it comes to transmission and the COVID-19 deaths, the vaccine appears not to have a protective effect. And the drawbacks? They were significant, as I have pointed out.
In addition, we have seen significant excess mortality among young people in both 2023 and 2024, as well as a sharp increase in the use of heart medication among young people from 2021 onwards – the first year with the COVID-19 vaccine. And if these grim figures were not enough, the Norwegian Institute of Public Health can now report that – after a decline in the number of people with cardiovascular disease from 2019 to 2020 – there was an increased incidence of high blood pressure and heart failure from 2021 to 2025 (age-standardized rates from 2021).
We cannot necessarily attribute all of these grim statistics solely to the COVID-19 vaccine, but since the documented drawbacks were substantial and the benefits at best non-existent, I stand by my earlier position [cf. below] that young people who declined the COVID-19 vaccine made the best choice.
In some population groups, fewer young people got vaccinated against COVID-19 than the rest of the population (1), and it is relevant to ask if those who abstained made a poor choice. No, they didn't. Peer-reviewed longitudinal analyses of young people in England show significantly increased mortality in 10 out of 11 weeks after vaccination compared with the first week, and at least doubled mortality in three weeks (2).
The findings may seem to contradict Norwegian data showing a 30% lower mortality rate among young people vaccinated against COVID-19 compared with unvaccinated people, and a difference of up to 58% when control variables were included (3). However, the figures say little about the vaccine effect since COVID-19-related deaths were close to zero in the relevant age group (4). What they do tell us, however, is that vaccinated and unvaccinated people initially have very different health profiles, as shown in England (5), which makes direct comparisons problematic. Furthermore, the figures show that the inclusion of control variables can make results more, not less, unreliable, as noted in relevant references (5). The figures should therefore give food for thought when considering the extensive research literature on corona vaccination.
If one studies the Norwegian data in more detail, they show a 13% increase in mortality among fully vaccinated young people from 2022 to 2023 (3). For the oldest age group, where the populations of fully vaccinated and unvaccinated people in the two years were more stable and therefore more comparable, the increase was 41%. This is in line with English data that also shows a marked relative increase in mortality among vaccinated people over time, with no other viable explanation than that the coronavirus vaccine has fatal, undesirable consequences (5). Unvaccinated people, especially young unvaccinated people, have therefore made a good choice. A very good one.
Litteratur:
1. Skogheim TS, Hussaini L. Koronavaksinering blant unge med innvandrerbakgrunn. Tidsskrift for Den norske legeforening. 2024;144(5). doi: 10.4045/tidsskr.24.0158
2. Aarstad J. Deaths among young people in England increased significantly in 10 of 11 weeks after COVID-19 vaccination and doubled in three. Excli j. 2024;23:908-11. doi: 10.17179/excli2024-7498
3. Dahl J, Tapia G, Boas H, Landsjoasen Bakken IJ, Lovdal Gulseth H. COVID-19 mRNA-vaccination and all-cause mortality in the adult population in Norway during 2021-2023: a population-based cohort study. doi: https://doi.org/10.1101/2024.12.15.24319058
4. Folkehelseinstituttet. FHI Statistikk. Dødsfall etter kjønn, alder og dødsårsak, antall 2024. https://statistikk.fhi.no/daar/4WsXdiMduftCsG6aAND9Yg?MEASURE_TYPE=Freq&DAAR=2021,2022,2023&KJONN=Total&ALDER=Total,4,5&EU_SHORT_CODE=Total,18_1,18_2. Lest 24.01.2025.
5. Aarstad J. The Temporal Protection and Declining Health of the COVID-19 Vaccinated in England: A 26-Month Comparison of the Mortality Involving and Not Involving COVID-19 Among Vaccinated vs. Unvaccinated. Preprints: Preprints; 2024. https://www.preprints.org/manuscript/202412.1874/v1 Lest 24.01.2025.
____________________________________________________________________________________________
Image: © Business Standard. Translation + Copyread: Google + Grammarly In line with our policies, we address notices of alleged violations under the United States "Digital Millennium Copyright Act" (DMCA). If you believe that your copyright has been infringed on our site, please contact us, and we will promptly remove your photo from display. editor@a-w-i-p.com. AWIP